Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

Posserud, Iris, Stotzer, Per-Ove, Björnsson, Einar S, Abrahamsson, Hasse, Simrén, Magnus·2007·Gut
DOI 10.1136/gut.2006.108712

Cited by (498)

Items 101–200 of 498

  1. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin
    Peralta, Sergio, Cottone, Claudia, Doveri, Tiziana, Almasio, Piero Luigi, Craxi, Antonio · 2009 · World Journal of Gastroenterology
  2. Upper gastrointestinal microbiota and digestive diseases
    Zi-Kai Wang · 2013 · World Journal of Gastroenterology
  3. Randomized double blind placebo-controlled trial of<i>Saccharomyces cerevisiae</i>CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
    Spiller, Robin, Pélerin, Fanny, Cayzeele Decherf, Amélie, Maudet, Corinne, Housez, Béatrice, Cazaubiel, Murielle, Jüsten, Peter · 2016 · United European Gastroenterology Journal
  4. Effects of Rifaximin Treatment and Retreatment in Nonconstipated IBS Subjects
    Pimentel, Mark, Morales, Walter, Chua, Kathleen, Barlow, Gillian, Weitsman, Stacy, Kim, Gene, Amichai, Meridythe M., Pokkunuri, Venkata, Rook, Emily, Mathur, Ruchi et al. · 2011 · Digestive Diseases and Sciences
  5. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: Frequency and predictors
    Sanjeev Sachdeva, Anushka Rawat, R. Sneha Latha Reddy, Amarender Singh Puri · 2011 · Journal of Gastroenterology and Hepatology
  6. Review article: abdominal bloating and distension in functional gastrointestinal disorders – epidemiology and exploration of possible mechanisms
    A. Agrawal, Peter James Whorwell · 2007 · Alimentary Pharmacology & Therapeutics
  7. A New Rat Model Links Two Contemporary Theories in Irritable Bowel Syndrome
    Mark Pimentel, Soumya Chatterjee, Christopher Chang, Kimberly Low, Yuli Song, Chengxu Liu, Walter Morales, Lemeesa Ali, Sheila Lezcano, Jeffery Conklin et al. · 2007 · Digestive Diseases and Sciences
  8. Abdominal Bloating: Pathophysiology and Treatment
    A Young Seo, Nayoung Kim, Dong Hyun Oh · 2013 · Journal of Neurogastroenterology and Motility
  9. Disorders of the Autonomic Nervous System
    Thomas C. Chelimsky, David Mark Robertson, Gisela G. Chelimsky · 2012 · Elsevier eBooks
  10. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth
    Manuele Furnari, A. Parodi, Lorenzo Gemignani, Edoardo Giovanni Giannini, S. Marenco, Edoardo Vincenzo Savarino, Lorenzo Assandri, V. Fazio, Daria Bonfanti, Simona Inferrera et al. · 2010 · Alimentary Pharmacology & Therapeutics
  11. The enteric microbiota in the pathogenesis and management of constipation
    Eamonn M.M. Quigley · 2011 · Best Practice & Research Clinical Gastroenterology
  12. Irritable bowel syndrome
    Nicholas J. Talley · 2006 · Internal Medicine Journal
  13. Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
    Ali Ranjideh Rezaie, Zeev Heimanson, Richard W. McCallum, Mark Pimentel · 2019 · The American Journal of Gastroenterology
  14. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link
    Uday C. Ghoshal, Kok‐Ann Gwee · 2017 · Nature Reviews Gastroenterology & Hepatology
  15. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth
    Uday C. Ghoshal, Deepakshi Srivastava, Asha Misra, Ujjala Ghoshal · 2016 · European Journal of Gastroenterology & Hepatology
  16. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment
    Vanner, S · 2008 · Gut
  17. B‐cell activation in patients with irritable bowel syndrome (IBS)
    öhman, L., Lindmark, A.‐c., Isaksson, S., Posserud, I., Strid, H., Sjövall, H., Simrén, M. · 2009 · Neurogastroenterology &amp; Motility
  18. Comparison of Lactulose and Glucose Breath Test for Diagnosis of Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome
    SurinderSingh Rana, Sadhna Sharma, Jaspreet Kaur, Saroj Kant Sinha, Kartar Singh · 2012 · Digestion
  19. Small Intestinal Clustered Contractions and Bacterial Overgrowth: A Frequent Finding in Obese Patients
    Ana María Madrid, Jaime Poníachik, Rodrigo Quera, C Defilíppí · 2010 · Digestive Diseases and Sciences
  20. Probiotics in the Management of Functional Bowel Disorders
    Eamonn M.M. Quigley · 2012 · Gastroenterology Clinics of North America
  21. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea
    Mark Pimentel · 2015 · Alimentary Pharmacology & Therapeutics
  22. Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity
    Marie C. M. Halliez, Jean‐Paul Motta, Troy D. Feener, Gaetan Guérin, Laëtitia Le Goff, Arnaud François, Élodie Colasse, Loïc Favennec, Gilles Gargala, Tamia K. Lapointe et al. · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  23. Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease
    Clett Erridge · 2011 · Atherosclerosis
  24. The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome
    Ashton J Harper, Malwina Naghibi, Davinder S. Garcha · 2018 · Foods
  25. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
    Savio Charan Reddymasu, Sandra Sostarich, Richard W. McCallum · 2010 · BMC Gastroenterology
  26. Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea
    Xinqing Fan, Joseph H. Sellin · 2009 · Alimentary Pharmacology & Therapeutics
  27. A meta‐analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome
    Uday C. Ghoshal, Abhimanyu Nehra, Akash Mathur, Sushmita Rai · 2019 · Journal of Gastroenterology and Hepatology
  28. Altered intestinal microbiota in irritable bowel syndrome: Microbiota in IBS
    Lee, K. J., Tack, J. · 2010 · Neurogastroenterology &amp; Motility
  29. Questioning the Bacterial Overgrowth Hypothesis of Irritable Bowel Syndrome: An Epidemiologic and Evolutionary Perspective
    Spiegel, Brennan M.R. · 2011 · Clinical Gastroenterology and Hepatology
  30. Bacteria: A New Player in Gastrointestinal Motility Disorders—Infections, Bacterial Overgrowth, and Probiotics
    Quigley, Eamonn M.M. · 2007 · Gastroenterology Clinics of North America
  31. Treatment of irritable bowel syndrome with probiotics: An etiopathogenic approach at last?
    Miguel Bixquert Jiménez · 2009 · Revista Española de Enfermedades Digestivas
  32. Clinical Implications of Lactose Malabsorption Versus Lactose Intolerance
    Michael D. Levitt, Timothy J Wilt, Aasma Shaukat · 2013 · Journal of Clinical Gastroenterology
  33. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI)
    Hazel Ní Chonchubhair, Yasir Bashir, Mark Dobson, Barbara Mary Ryan, Sinead Noelle Duggan, Kevin C. Conlon · 2018 · Pancreatology
  34. Positive Glucose Breath Testing is More Prevalent in Patients With IBS-like Symptoms Compared With Controls of Similar Age and Gender Distribution
    Andrea Ferretto Parodi, Pietro Dulbecco, Edoardo Vincenzo Savarino, Edoardo Giovanni Giannini, Giorgia Bodini, Marina Corbo, Luca Isola, Stefano De Conca, Elisa Marabotto, Vincenzo Savarino · 2009 · Journal of Clinical Gastroenterology
  35. Review: The treatment of irritable bowel syndrome
    Brian E. Lacy, Kirsten Weiser, Ryan De Lee · 2009 · Therapeutic Advances in Gastroenterology
  36. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro‐cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients
    Jimeng Zhao, Xia Zheng, H. Chu, Jimeng Zhao, Yuchen Cong, Michael Fried, Mark R. Fox, Ning Dai · 2014 · Neurogastroenterology & Motility
  37. Updates on treatment of irritable bowel syndrome
    Christopher W. Hammerle, Christina M. Surawicz · 2008 · World Journal of Gastroenterology
  38. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation.
    Manuele Furnari, Edoardo Vincenzo Savarino, Luca Bruzzone, Alessandro Moscatelli, Lorenzo Gemignani, Edoardo Giovanni Giannini, Patrizia Zentilin, Pietro Dulbecco, Savarino · 2012 · PubMed
  39. Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut–Skin Axis of Rosacea
    Fang‐Ying Wang, Ching‐Chi Chi · 2021 · Advances in Therapy
  40. Probiotics in functional gastrointestinal disorders: what are the facts?
    Eamonn M.M. Quigley · 2008 · Current Opinion in Pharmacology
  41. Small intestinal motility
    Michael P Jones, Jason R. Bratten · 2008 · Current Opinion in Gastroenterology
  42. Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation
    Ruchit Sood, Michael Camilleri, David J. Gracie, Matthew J Gold, Natalie To, Graham Richard Law, Alexander Charles Ford · 2016 · The American Journal of Gastroenterology
  43. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases
    Johanna Sundin, Lena Öhman, Magnus Simrén · 2017 · Psychosomatic Medicine
  44. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months
    Pierre Meyrat, Ekaterina Safroneeva, Alain M. Schoepfer · 2012 · Alimentary Pharmacology & Therapeutics
  45. Effects of Medium Chain Fatty Acids on Intestinal Health of Monogastric Animals
    Manyi Jia, Yucheng Zhang, Yuqi Gao, Xi Ma · 2019 · Current Protein and Peptide Science
  46. Peripheral factors in the pathophysiology of irritable bowel syndrome
    Gunnarsson, J., Simrén, M. · 2009 · Digestive and Liver Disease
  47. Treating irritable bowel syndrome with probiotics: the evidence
    Gareth C. Parkes, Jeremy David Sanderson, Kevin Whelan · 2010 · Proceedings of The Nutrition Society
  48. Breath tests and irritable bowel syndrome
    Satya Vati Rana · 2014 · World Journal of Gastroenterology
  49. Small Intestinal Bacterial Overgrowth in Gastroparesis: Are There Any Predictors?
    Reddymasu, Savio C., McCallum, Richard W. · 2010 · Journal of Clinical Gastroenterology
  50. Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome
    Aiysha Thompson, Dilruba Meah, Nadia Ahmed, Rebecca Conniff-Jenkins, Emma Chileshe, Chris Phillips, Tim C. Claypole, Dan W. Forman, Paula E. Row · 2013 · BMC Complementary and Alternative Medicine
  51. Update on Irritable Bowel Syndrome and Gender Differences
    Margaret McLean Heitkemper, Monica E. Jarrett · 2008 · Nutrition in Clinical Practice
  52. The Intestinal Microbiota and Irritable Bowel Syndrome
    Yehuda Ringel, Tamar Ringel‐Kulka · 2015 · Journal of Clinical Gastroenterology
  53. Estimating the Contribution of Acute Gastroenteritis to the Overall Prevalence of Irritable Bowel Syndrome
    Eric D. Shah, Mark S. Riddle, Christopher Chang, Mark Pimentel · 2012 · Journal of Neurogastroenterology and Motility
  54. In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth
    Aikaterini C. Pistiki, Irene Galani, Emmanouel Pyleris, Charalambos Barbatzas, Mark Pimentel, Evangelos J. Giamarellos‐Bourboulis · 2014 · International Journal of Antimicrobial Agents
  55. Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel syndrome
    Jordi Serra, Albert Villòria, Fernando Azpiroz, Beatriz Lobo, Javier Santos, Anna M. Accarino, J. R. Malagelada · 2009 · Neurogastroenterology & Motility
  56. Show Me What You Have Inside—The Complex Interplay between SIBO and Multiple Medical Conditions—A Systematic Review
    Natalia Sroka, Alicja Rydzewska–Rosołowska, Katarzyna Kakareko, Mariusz Rosołowski, Irena Głowińska, Tomasz Hryszko · 2022 · Nutrients
  57. Stimulants of Toll-like receptors 2 and 4 are elevated in saliva of periodontitis patients compared with healthy subjects
    David Francis Lappin, Sakhr Sherrabeh, Clett Erridge · 2011 · Journal Of Clinical Periodontology
  58. Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy
    Shunji Ishihara, Kazuo Yashima, Yoshinori Kushiyama, Akio Izumi, Kousaku Kawashima, Hirofumi Fujishiro, Haruhiko Kojo, Yoshinori Komazawa, Tetsuro Hamamoto, Tetsuo Yamamoto et al. · 2012 · Journal of Gastroenterology
  59. Orocecal Transit Time and Small Intestinal Bacterial Overgrowth in Type 2 Diabetes Patients from North India
    Satyavati V. Rana, Anil Bhansali, Sanjay Kumar Bhadada, Surendra Kumar Sharma, Jaspreet Kaur, Kartar Singh · 2011 · Diabetes Technology & Therapeutics
  60. Obesity increases the risk of small intestinal bacterial overgrowth ( SIBO )
    Bani Chander Roland, D. Lee, Larry S. Miller, Anil K. Vegesna, Robert H. Yolken, Emily G. Severance, Emese Prandovszky, Xi Zheng, Gerard E. Mullin · 2017 · Neurogastroenterology & Motility
  61. Small Intestinal Bacterial Overgrowth Syndrome: A Guide for the Appropriate Use of Breath Testing
    Benson T. Massey, Arnold M. Wald · 2020 · Digestive Diseases and Sciences
  62. Irritable Bowel Syndrome: Modern Concepts and Management Options
    Gregory S. Sayuk, Chandra Prakash Gyawali · 2015 · The American Journal of Medicine
  63. Bowel Disorders
    Robert E. Spiller, Grant W. Thompson · 2010 · The American Journal of Gastroenterology
  64. The Malabsorption of Commonly Occurring Mono and Disaccharides
    Martin Raithel, Michael Weidenhiller, Alexander Hagel, Urban Hetterich, Markus Friedrich Neurath, Peter Christopher Konturek · 2013 · Deutsches Ärzteblatt international
  65. Small bowel bacterial overgrowth in adults: A potential contributor to intestinal failure
    Thomas R. Ziegler, Conrad R. Cole · 2007 · Current Gastroenterology Reports
  66. Wuji Wan Formula Ameliorates Diarrhea and Disordered Colonic Motility in Post-inflammation Irritable Bowel Syndrome Rats by Modulating the Gut Microbiota
    Ying Chen, Shuiming Xiao, Zipeng Gong, Xiaoxin Zhu, Qing Yang, Yujie Li, Shuangrong Gao, Yu Juan Dong, Zhe Shi, Yajie Wang et al. · 2017 · Frontiers in Microbiology
  67. Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome
    Boris Le Nevé, Rémi Brazeilles, Muriel Derrien, Julien Tap, Denis Guyonnet, Lena Öhman, Hans Törnblom, Magnus Simrén · 2015 · Clinical Gastroenterology and Hepatology
  68. Breath Tests for Gastrointestinal Disease: The Real Deal or Just a Lot of Hot Air?
    Richard J. Saad, William D. Chey · 2007 · Gastroenterology
  69. Symptomatic fructose malabsorption in irritable bowel syndrome: A prospective study
    Chloé Melchior, Guillaume Gourcerol, Pierre Déchelotte, Anne‐Marie Leroi, Philippe R. Ducrotte · 2014 · United European Gastroenterology Journal
  70. Critical Evaluation of Diagnosing Bacterial Overgrowth in the Proximal Small Intestine
    Angèle P. M. Kerckhoffs, M. R. Visser, Melvin Samsom, Michel E. van der Rest, Joris de Vogel, W. C. M. Harmsen-van Amerongen, Louis M. A. Akkermans · 2008 · Journal of Clinical Gastroenterology
  71. Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study.
    SurinderSingh Rana, S K Sinha, Arbab Sikander, Bhasin Dk, K Singh · 2008 · PubMed
  72. Irritable bowel syndrome: new and emerging treatments
    Magnus Halland, Y. A. Saito · 2015 · BMJ
  73. Antibiotics for the treatment of irritable bowel syndrome.
    Robert J. Basseri, Stacy R. Weitsman, Gillian M. Barlow, Mark Pimentel · 2011 · Europe PMC (PubMed Central)
  74. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
    Aziz, Imran, Törnblom, Hans, Simrén, Magnus · 2017 · Current Opinion in Gastroenterology
  75. The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome
    Brian E. Lacy · 2015 · Clinical Gastroenterology and Hepatology
  76. The Relationship between Small-Intestinal Bacterial Overgrowth and Intestinal Permeability in Patients with Irritable Bowel Syndrome
    Jung Ho Park, Dong Il Park, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyoung Hee Won, Soon Min Park · 2009 · Gut and Liver
  77. ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS
    Sam-Ryong Jee · 2010 · World Journal of Gastroenterology
  78. Intestinal and anorectal motility and functional disorders
    Jutta Keller, Peter Layer · 2009 · Best Practice & Research Clinical Gastroenterology
  79. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome
    Julia König, Robert J. Brummer · 2014 · Beneficial Microbes
  80. Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth
    David Yamini, Mark Pimentel · 2010 · Journal of Clinical Gastroenterology
  81. The Effect of Rifaximin on Gut Flora and Staphylococcus Resistance
    Mi-Sung Kim, Walter Morales, Andres Ardila Hani, Sharon H. Kim, Gene H. Kim, Stacy R. Weitsman, Christopher Chia-Chi Chang, Mark Pimentel · 2013 · Digestive Diseases and Sciences
  82. Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment
    Robert E. Spiller · 2016 · F1000Research
  83. New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility.
    Antonio Gasbarrini, Ernesto Cristiano Lauritano, Matteo Garcovich, Lucia Sparano, Antonio Gasbarrini · 2008 · PubMed
  84. Antibiotics for Irritable Bowel Syndrome: Rationale and Current Evidence
    Amit H. Sachdev, Mark Pimentel · 2012 · Current Gastroenterology Reports
  85. Small Bowel Bacterial Overgrowth in Children
    Agnieszka Sieczkowska, Piotr Landowski, Barbara Kamińska, Carlos H. Lifschitz · 2015 · Journal of Pediatric Gastroenterology and Nutrition
  86. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome
    Prashant Singh, Anthony J Lembo · 2021 · Gastroenterology Clinics of North America
  87. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders
    Yehuda Ringel · 2017 · Gastroenterology Clinics of North America
  88. A Combined Nutrient and Lactulose Challenge Test Allows Symptom-Based Clustering of Patients With Irritable Bowel Syndrome
    Boris Le Nevé, Iris Posserud, Lena Böhn, Denis Guyonnet, Pascale Rondeau, Kirsten Tillisch, Bruce D. Naliboff, Emeran A. Mayer, Magnus Simrén · 2013 · The American Journal of Gastroenterology
  89. Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship
    Jun Gao, Merritt G. Gillilland, Chung Owyang · 2014 · Gut Microbes
  90. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review
    Max Julio Schmulson, María Victoria Bielsa, Ramón Carmona-Sánchez, Angélica Hernández, Aurelio López‐Colombo, Yolanda López‐Vidal, Mario Peláez‐Luna, José María Remes-Troche, José Luis Tamayo, Miguel Angel Valdovinos · 2014 · Revista de Gastroenterología de México (English Edition)
  91. Short article: Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children
    Kristen Cares, Namir Al‐Ansari, Suhasini Macha, Najeeb Zoubi, Hazim Zaghloul, Ron Thomas, Patricia Lalinsky, Mohammad El‐Baba · 2017 · European Journal of Gastroenterology & Hepatology
  92. Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.
    Mark Pimentel, Walter Morales, Sheila Lezcano, Sun-Chuan Dai, Kimberly Low, Janet Miyoung Yang · 2009 · PubMed Central
  93. Do gut microbial communities differ in pediatric IBS and health?
    Vijay Shankar, Richard Agans, Benjamin Holmes, Michael G. Raymer, Oleg Paliy · 2013 · Gut Microbes
  94. Gastrointestinal Pharmacology
    Miguel Saps, Adrian Miranda · 2017 · Handbook of experimental pharmacology
  95. Irritable bowel syndrome: Bacterial overgrowth—What’s known and what to do
    Mark Pimentel, Sheila Lezcano · 2007 · Current Treatment Options in Gastroenterology
  96. The Lactulose Breath Test for Diagnosing SIBO in IBS Patients: Another Nail in the Coffin
    Stephen J. Vanner · 2008 · The American Journal of Gastroenterology
  97. Proton Pump Inhibitor Therapy Does Not Affect Hydrogen Production on Lactulose Breath Test in Subjects with IBS
    Law, David, Pimentel, Mark · 2010 · Digestive Diseases and Sciences
  98. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of Knowledge
    Paulina Roszkowska, Emilia Klimczak, Ewa Ostrycharz, Aleksandra Rączka, Iwona Wojciechowska‐Koszko, Andrzej Dybus, Yeong-Hsiang Cheng, Yu‐Hsiang Yu, Szymon Mazgaj, Beata Hukowska-Szematowicz · 2024 · Biomedicines
  99. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
    John S. Kane, Alexander Charles Ford · 2016 · Expert Review of Gastroenterology & Hepatology
  100. Small Intestinal Bacterial Overgrowth
    Edward J. Krajicek, Stephanie L. Hansel · 2016 · Mayo Clinic Proceedings